Abstract | BACKGROUND: CASE REPORT: CONCLUSION:
|
Authors | S Mishra, L Connors, B Tugwell |
Journal | Diabetic medicine : a journal of the British Diabetic Association
(Diabet Med)
Vol. 35
Issue 5
Pg. 663-666
(05 2018)
ISSN: 1464-5491 [Electronic] England |
PMID | 29381818
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Copyright | © 2018 Diabetes UK. |
Chemical References |
- Anti-Allergic Agents
- Insulin
- Omalizumab
- Insulin Glargine
- Insulin Detemir
- Insulin, Isophane
- insulin glulisine
- Insulin Aspart
|
Topics |
- Anaphylaxis
(etiology, prevention & control)
- Anti-Allergic Agents
(therapeutic use)
- Diabetes Mellitus, Type 2
(drug therapy)
- Drug Hypersensitivity
(drug therapy, etiology)
- Humans
- Insulin
(adverse effects, analogs & derivatives, therapeutic use)
- Insulin Aspart
(adverse effects)
- Insulin Detemir
(adverse effects, therapeutic use)
- Insulin Glargine
(adverse effects)
- Insulin, Isophane
(adverse effects)
- Male
- Middle Aged
- Omalizumab
(therapeutic use)
|